Rafael Holdings
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2017-01-01
- Employees
- 13
- Market Cap
- $36.3M
- Introduction
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. It operates through the Healthcare and Real Estate segments. The Healthcare segment relates to the activities of LipoMedix, Barer, Farber, and Rafael Medical Devices. The company was founded in 2017 and is headquartered in Newark, NJ.
Cyclo Therapeutics Enters into Significant Note Purchase Agreement with Rafael Holdings
Cyclo Therapeutics, Inc. entered a Seventh Amended and Restated Note Purchase Agreement with Rafael Holdings, Inc., involving a $3,000,000 convertible promissory note at 5% interest, maturing February 15, 2025. Rafael can convert the note into Cyclo's stock under certain conditions. The funds are for working capital. Rafael owns 39.5% of Cyclo's stock, and a merger agreement is in place, pending conditions and approvals.
© Copyright 2025. All Rights Reserved by MedPath